Ibuprofeno B. Braun

Ibuprofen, the active ingredient in Ibuprofeno B. Braun, is a nonsteroidal anti-inflammatory drug presented as an injectable solution for intravenous use. It treats pain, fever and inflammation in hospital settings.

GNH USA supplies Ibuprofeno B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that reduces pain, fever and inflammation by inhibiting prostaglandin synthesis.

Pain: Provides analgesic relief for acute and chronic painful conditions. Fever: Lowers elevated body temperature in adults and children. Inflammation: Decreases swelling associated with musculoskeletal and postoperative inflammation. Post‑operative pain: Controls moderate to severe pain after surgical procedures.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea or vomiting - Dyspepsia or abdominal discomfort - Headache - Dizziness - Injection‑site pain or erythema - Transient rise in blood pressure

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Acute renal impairment or failure - Severe hypersensitivity reactions, including anaphylaxis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Thrombocytopenia or other hematologic abnormalities - Hepatotoxicity with elevated liver enzymes

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.

Renal function: Assess baseline kidney function and adjust use in patients with chronic renal disease. Cardiovascular risk: Use cautiously in individuals with hypertension or heart failure. Bleeding tendency: Avoid in patients with active peptic ulcer disease or coagulopathy. Pregnancy category D: Limit use to situations where benefits outweigh risks, especially after the first trimester. Drug interactions: Review concomitant medications for additive NSAID effects. Store at ambient temperature: Keep in original container, protect from light and moisture.

Ibuprofeno B. Braun may alter the pharmacodynamics or pharmacokinetics of several co‑administered agents.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - SSRIs or SNRIs: heightened bleeding potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, especially in volume‑depleted patients. - Diuretics: potential for reduced renal clearance of ibuprofen. - Lithium: ibuprofen can raise serum lithium concentrations, requiring level monitoring.